U.S. Trends: Synthetic Opioid Production Remains Strong

in health •  9 years ago  (edited)

DEA established quotas for production of Oxycodone, a semi-synthetic opioid, have nearly quadrupled since the start of the millennium. Oxycodone is a potent painkiller derived from the Persian Poppy, with a high potential for addiction.

2009 was the height of the "Pill Mill" epidemic in South Florida, yet by 2013, nationwide production quotas for Oxycodone had increased 98%. Between 2012 and 2013 alone, production quotas showed a huge jump of 46%. During the roughly same period (2009-2013), the U.S. population increased by only 3%, from about 306 to 316 million. Since 2013, productions quotas have declined somewhat, but still remain 79% above the 2009 level.

DEA Established Oxycodone Production Quotas (for sale, grams)

YearProduction Quota (g)Percent +/-
2016139,150,000- 1.6%
2015141,375,000- 5.4%
2014149,375,000- 2.9%
2013153,750,000+ 46.2%
2012105,200,000+ 7.3%
201198,000,000- 7.2%
2010105,500,000+ 36%
200977,560,000+ 53.6%
200550,490,000+ 40.8%
200035,850,000NA

Sources:
Federal Register - 2000 Quotas
Federal Register - 2005 Quotas
Federal Register - 2009 Quotas
Federal Register - 2010 Quotas
Federal Register - 2011 Quotas
Federal Register - 2012 Quotas
Federal Register - 2013 Quotas
Federal Register - 2014 Quotas
Federal Register - 2015 Quotas
Federal Register - 2016 Quotas
Wikipedia
rxlist
U.S. Census

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!
Sort Order: